These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2357012)

  • 21. Estrogen metabolism and the malignant potential of human papillomavirus immortalized keratinocytes.
    Newfield L; Bradlow HL; Sepkovic DW; Auborn K
    Proc Soc Exp Biol Med; 1998 Mar; 217(3):322-6. PubMed ID: 9492342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of CYP1A1 and CYP1B1 in T-47D human breast cancer cells by benzo[a]pyrene is diminished by arsenite.
    Spink DC; Katz BH; Hussain MM; Spink BC; Wu SJ; Liu N; Pause R; Kaminsky LS
    Drug Metab Dispos; 2002 Mar; 30(3):262-9. PubMed ID: 11854143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of serum albumin on estrogen metabolism in human cancer cell lines.
    Bradlow HL; Arcuri F; Blasi L; Castagnetta L
    Mol Cell Endocrinol; 1995 Dec; 115(2):221-5. PubMed ID: 8824898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 15- and 16-hydroxylations of androgens and estrogens in the human fetal liver: a critical step in estetrol biosynthesis.
    Cantineau R; Kremers P; De Graeve J; Gielen JE; Lambotte R
    J Steroid Biochem; 1985 Feb; 22(2):195-201. PubMed ID: 3157024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol.
    Badawi AF; Cavalieri EL; Rogan EG
    Metabolism; 2001 Sep; 50(9):1001-3. PubMed ID: 11555828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preneoplastic transformation in mouse mammary tissue: identification and validation of intermediate biomarkers for chemoprevention.
    Telang NT; Kurihara H; Wong GY; Bradlow HL; Osborne MP
    Anticancer Res; 1991; 11(3):1021-7. PubMed ID: 1909512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
    Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis.
    Auborn KJ; Woodworth C; DiPaolo JA; Bradlow HL
    Int J Cancer; 1991 Dec; 49(6):867-9. PubMed ID: 1660039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased 16 alpha-hydroxylation of estradiol in systemic lupus erythematosus.
    Lahita RG; Bradlow HL; Kunkel HG; Fishman J
    J Clin Endocrinol Metab; 1981 Jul; 53(1):174-8. PubMed ID: 7240374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue-specific synthesis and oxidative metabolism of estrogens.
    Jefcoate CR; Liehr JG; Santen RJ; Sutter TR; Yager JD; Yue W; Santner SJ; Tekmal R; Demers L; Pauley R; Naftolin F; Mor G; Berstein L
    J Natl Cancer Inst Monogr; 2000; (27):95-112. PubMed ID: 10963622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and environmental determinants on tissue response to in vitro carcinogen exposure and risk of breast cancer.
    Li D; Walcott FL; Chang P; Zhang W; Zhu J; Petrulis E; Singletary SE; Sahin AA; Bondy ML
    Cancer Res; 2002 Aug; 62(16):4566-70. PubMed ID: 12183407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.
    Hanna IH; Dawling S; Roodi N; Guengerich FP; Parl FF
    Cancer Res; 2000 Jul; 60(13):3440-4. PubMed ID: 10910054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel.
    Gentile DM; Verhoeven CH; Shimada T; Back DJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):975-82. PubMed ID: 9864282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone.
    Baldwin SJ; Clarke SE; Chenery RJ
    Br J Clin Pharmacol; 1999 Sep; 48(3):424-32. PubMed ID: 10510156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal oxidative metabolism of estradiol in women with breast cancer.
    Schneider J; Kinne D; Fracchia A; Pierce V; Anderson KE; Bradlow HL; Fishman J
    Proc Natl Acad Sci U S A; 1982 May; 79(9):3047-51. PubMed ID: 6953448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of oxidative DNA damage during the metabolic activation of benzo[a]pyrene in human mammary epithelial cells correlates with cell killing.
    Leadon SA; Stampfer MR; Bartley J
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4365-8. PubMed ID: 3380798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17 beta-estradiol metabolism in MCF-7 breast tumor cells.
    Spink DC; Lincoln DW; Dickerman HW; Gierthy JF
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6917-21. PubMed ID: 2395886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pattern and rates of metabolism of maternal plasma dehydroisoandrosterone sulfate in human pregnancy.
    Madden JD; Siiteri PK; MacDonald PC; Gant NF
    Am J Obstet Gynecol; 1976 Aug; 125(7):915-20. PubMed ID: 133611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer.
    Fishman J; Schneider J; Hershcope RJ; Bradlow HL
    J Steroid Biochem; 1984 Apr; 20(4B):1077-81. PubMed ID: 6727352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: a potential pathway of metabolic activation of estrogens.
    Weisz J; Bui QD; Roy D; Liehr JG
    Endocrinology; 1992 Aug; 131(2):655-61. PubMed ID: 1386303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.